- Home
- KMDA vs KIO Comparison
KMDA vs KIO Comparison
Compare KMDA & KIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- KIO
- Stock Information
- Founded
- KMDA 1990
- KIO 2011
- Country
- KMDA Israel
- KIO United States
- Employees
- KMDA N/A
- KIO 2400
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- KIO Investment Managers
- Sector
- KMDA Health Care
- KIO Finance
- Exchange
- KMDA Nasdaq
- KIO Nasdaq
- Market Cap
- KMDA 443.4M
- KIO 514.6M
- IPO Year
- KMDA N/A
- KIO N/A
- Fundamental
- Price
- KMDA $7.72
- KIO $12.63
- Analyst Decision
- KMDA Strong Buy
- KIO
- Analyst Count
- KMDA 2
- KIO 0
- Target Price
- KMDA $13.00
- KIO N/A
- AVG Volume (30 Days)
- KMDA 55.4K
- KIO 136.5K
- Earning Date
- KMDA 08-13-2025
- KIO 01-01-0001
- Dividend Yield
- KMDA 2.59%
- KIO 10.82%
- EPS Growth
- KMDA 31.21
- KIO N/A
- EPS
- KMDA 0.28
- KIO N/A
- Revenue
- KMDA $167,235,000.00
- KIO N/A
- Revenue This Year
- KMDA $14.51
- KIO N/A
- Revenue Next Year
- KMDA $9.31
- KIO N/A
- P/E Ratio
- KMDA $28.31
- KIO N/A
- Revenue Growth
- KMDA 11.83
- KIO N/A
- 52 Week Low
- KMDA $5.08
- KIO $10.52
- 52 Week High
- KMDA $9.16
- KIO $13.59
- Technical
- Relative Strength Index (RSI)
- KMDA 53.97
- KIO 60.79
- Support Level
- KMDA $7.64
- KIO $12.54
- Resistance Level
- KMDA $7.91
- KIO $12.81
- Average True Range (ATR)
- KMDA 0.18
- KIO 0.08
- MACD
- KMDA -0.02
- KIO -0.01
- Stochastic Oscillator
- KMDA 50.00
- KIO 51.35
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About KIO KKR Income Opportunities Fund
KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.